Stockscreener 앱 받기
9.36
6.40%
-0.64
전일 마감가:
$10.00
열려 있는:
$10.27
하루 거래량:
12,253
Relative Volume:
0.66
시가총액:
$16.65M
수익:
$12.88M
순이익/손실:
$-6.25M
주가수익비율:
-6.8481
EPS:
-1.3668
순현금흐름:
$-14.98M
1주 성능:
+20.46%
1개월 성능:
+5.76%
6개월 성능:
-46.18%
1년 성능:
+9,847%
1일 변동 폭
$8.8091
$10.27
1주일 범위
$7.2701
$10.93
52주 변동 폭
$7.21
$31.00
Palatin Technologies Inc. Stock (PTN) Company Profile
명칭
Palatin Technologies Inc.
전화
609-495-2200
주소
Cedar Brook Corporate Center, 4B Cedar Brook Drive, Cranbury, NJ
Compare PTN vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PTN
Palatin Technologies Inc.
|
9.36 | 16.85M | 12.88M | -6.25M | -14.98M | -1.3668 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Palatin Technologies Inc. Stock (PTN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-12 | 개시 | Laidlaw | Buy |
| 2025-12-03 | 개시 | Alliance Global Partners | Buy |
| 2015-06-05 | 재확인 | Canaccord Genuity | Buy |
| 2015-01-12 | 재확인 | ROTH Capital | Buy |
| 2012-05-23 | 개시 | Noble Financial | Buy |
| 2007-01-23 | 개시 | Next Generation | Buy |
모두보기
Palatin Technologies Inc. 주식(PTN)의 최신 뉴스
Palatin Technologies, Inc. Common Stock (NASDAQ: PTN) Share Price, PTN Stock News, PTN Share Price & Updates - Kalkine
Palatin Technologies (PTN) gains 4.7% stake holder AuGC BioFund in 13G/A - Stock Titan
Palatin Technologies Inc (PTN) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Palatin Technologies Inc (PTN) Stock News Today - tradingkey.com
StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It - Yahoo Finance
Q3 2026 Palatin Technologies Inc Earnings Call Transcript - GuruFocus
Palatin Technologies (PTN) director granted new 2,900-share stock option - Stock Titan
Palatin Technologies (PTN) director receives 2,400 new stock options - Stock Titan
Palatin Technologies (PTN) director receives 2,200 options at $7.70 - Stock Titan
Palatin Technologies Shareholders Back Governance and Incentive Plan - The Globe and Mail
PTN Q2 2026 Earnings: Significant EPS Beat Amid Pipeline Progress and Cost DisciplineEarnings Recovery Stocks - dars.gov.et
Palatin Technologies Inc (PTN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - tradingkey.com
Palatin Technologies Inc (PTN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PTN|Palatin Technologies Inc|Price:7.800|Chg%:+0.095 - TradingKey
Palatin Technologies Inc (PTN) Balance Sheet - TradingKey
Palatin Technologies Inc (PTN) Income Statement - TradingKey
TradingKey - TradingKey
PTN|Palatin Technologies Inc|Price:7.705|Chg%:-0.490 - TradingKey
Palatin Technologies Inc (PTN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Palatin Technologies Inc (PTN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Palatin Technologies, Inc. Revenue Breakdown – NASDAQ:PTN - TradingView
PTN|Palatin Technologies Inc|Price:8.030|Chg%:+0.325 - TradingKey
Palatin Technologies Inc (PTN) Institutional Confidence - TradingKey
What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare-Obesity Opportunity - TipRanks
What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare-Obesity Opportunit - Benzinga
Palatin stock trades quietly as revenue stabilizes after FY 2025 loss - Ad-hoc-news.de
Palatin Technologies (PTN) Gains Momentum: Stock Climbs 5.88% as Biotech Sector Shows StrengthEarly Entry Signals - dars.gov.et
Palatin Technologies (PTN) CFO has 195 shares withheld for taxes - Stock Titan
Palatin Technologies (PTN) CEO has 294 shares withheld for taxes - Stock Titan
Palatin Technologies explores drug pipeline as investors track Nasdaq listing - Ad-hoc-news.de
Price to cash flow ratio of Palatin Technologies, Inc. – NASDAQ:PTN - TradingView
PTN Q2 2026 Earnings: Narrower-than-Expected Loss Drives Positive Surprise but Stock DeclinesEarnings Yield Analysis - dars.gov.et
Tangible book value per share of Palatin Technologies, Inc. – NASDAQ:PTN - TradingView
Palatin Technologies (PTN) Surges 12.2%: Biotech Stock Breaks Above Key SupportSell Signal Alerts - dars.gov.et
A41E9H Forecast — Price Target — Prediction for 2027 - TradingView
Palatin Technologies, Inc.(NasdaqCM: PTN) added to Russell 3000E Index - marketscreener.com
Palatin Technologies, Inc.(NasdaqCM: PTN) added to Russell 3000E Growth Benchmark - marketscreener.com
Palatin Technologies, Inc.(NasdaqCM:PTN) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Palatin Technologies, Inc.(NasdaqCM: PTN) added to Russell Microcap Index - marketscreener.com
Palatin Technologies, Inc. Actuals & Estimates (LS:A41E9H) - TradingView
Price to book forward of Palatin Technologies, Inc. – NASDAQ:PTN - TradingView
Enterprise value to EBIT forward of Palatin Technologies, Inc. – NASDAQ:PTN - TradingView
Enterprise value to revenue forward of Palatin Technologies, Inc. – NASDAQ:PTN - TradingView
Palatin Technologies, Inc. Actuals & Estimates (NASDAQ:PTN) - TradingView
Palatin Technologies, Inc. Actuals & Estimates (BOATS:PTN) - TradingView
Form DEF 14A CorMedix Inc For: 25 June By Investing.com - Investing.com Nigeria
Palatin Technologies (PTN) proxy adds equity plan shares and director votes - Stock Titan
PTN Forecast — Price Target — Prediction for 2027 - TradingView
Palatin Technologies StockSunday background on the biotech’s path - ad-hoc-news.de
Palatin Technologies Inc (PTN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Palatin Technologies Inc (PTN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Palatin Technologies Inc. (PTN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.07%
자본화:
|
볼륨(24시간):